Global Fragment-based Drug Discovery Market Revenue (US$ Mn) by Technique
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Service
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on End Users
Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Region
Europe Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
North America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Asia Pacific Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Latin America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Middle East & Africa Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fragment-based Drug Discovery Market Snapshot
Chapter 4. Global Fragment-based Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Fragment-based Drug Discovery Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Type of Technique Estimates & Trend Analysis
5.1. Type of Technique & Market Share, 2020 & 2028
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Technique:
5.2.1. X-ray Crystallography
5.2.2. Nuclear Magnetic Resonance
5.2.3. Surface Plasmon Resonance
5.2.4. Other Screening Techniques
Chapter 6. Market Segmentation 1: Type of Service Estimates & Trend Analysis
6.1. Type of Service & Market Share, 2020 & 2028
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Service:
6.2.1. Library Screening
6.2.2. Fragment Screening
6.2.3. Fragment Optimization
Chapter 7. Fragment-based Drug Discovery Market Segmentation 2: End-Users Estimates & Trend Analysis
7.1. End-Users Analysis & Market Share, 2020 & 2028
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:
7.2.1. Industry Players
7.2.2. Non-industry Players
Chapter 8. Fragment-based Drug Discovery Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Technique, 2020-2028
8.1.2. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Service, 2020-2028
8.1.3. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028
8.1.4. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2020-2028
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.2.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.2.3. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.2.4. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.3.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.3.3. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.3.4. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million)
8.4.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.4.3. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, (US$ Million)
8.4.4. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 2020-2028
8.5.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.5.3. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.5.3.1. South Africa
8.5.3.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 2bind
9.2.2. Charles River Laboratories
9.2.3. ChemAxon
9.2.4. ComInnex
9.2.5. ChemDiv
9.2.6. Creative Biolabs
9.2.7. Creative Biostructure
9.2.8. CRELUX
9.2.9. Domainex
9.2.10. Evotec
9.2.11. Red Glead Discovery
9.2.12. SARomics Biostructures
9.2.13. Shanghai ChemPartner
9.2.14. Sygnature Discovery
9.2.15. Vernalis
9.2.16. Other Prominent Player
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.